We are live on ! Find out more
KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

82 hedge funds and large institutions have $110M invested in Chinook Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 29 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

179% more capital invested

Capital invested by funds: $39.2M → $110M (+$70.3M)

0% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 19

2% less funds holding

Funds holding: 84 → 82 (-2)

28% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 29

Holders
82
Holders Change
-2
Holders Change %
-2.38%
% of All Funds
1.81%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
19
Increased
21
Reduced
29
Closed
19
Calls
$235K
Puts
–
Net Calls
+$235K
Net Calls Change
+$204K

Top Buyers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
+$12.1M
2
IC
Ikarian Capital
Texas
+$4.26M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$3.99M
4
RCMNY
Rubric Capital Management (New York)
New York
+$2.06M
5
N
Nuveen
North Carolina
+$996K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$1.66M
2
Two Sigma Investments
Two Sigma Investments
New York
-$1.08M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$893K
4
BCM
Bridgeway Capital Management
Texas
-$730K
5
EAM
Erste Asset Management
Austria
-$674K
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
51
Ameriprise
Minnesota
$63K +$54.8K +4,632 New
Deutsche Bank
52
Deutsche Bank
Germany
$61K -$120K -10,160 -70%
Barclays
53
Barclays
United Kingdom
$60K -$104K -8,829 -67%
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
$59.1K +$27.9K +2,356 +120%
SSA
55
Schonfeld Strategic Advisors
New York
$58K +$50.1K +4,236 New
Walleye Capital
56
Walleye Capital
New York
$57K +$49.7K +4,200 New
CCA
57
Cobblestone Capital Advisors
New York
$55K – – –
Citigroup
58
Citigroup
New York
$54K +$15.6K +1,316 +50%
Susquehanna International Group
59
Susquehanna International Group
Pennsylvania
$52K -$106K -8,974 -70%
Victory Capital Management
60
Victory Capital Management
Texas
$52K +$45.3K +3,832 New
Ohio Public Employees Retirement System (OPERS)
61
Ohio Public Employees Retirement System (OPERS)
Ohio
$50K +$36K +3,042 +507%
State Board of Administration of Florida Retirement System
62
State Board of Administration of Florida Retirement System
Florida
$37K -$922 -78 -3%
Assenagon Asset Management
63
Assenagon Asset Management
Luxembourg
$34K -$893K -75,553 -97%
Morgan Stanley
64
Morgan Stanley
New York
$33K -$194K -16,379 -87%
MAM
65
Meeder Asset Management
Ohio
$32K +$28K +2,368 New
AB
66
Amalgamated Bank
New York
$31K +$331 +28 +1%
AIM
67
Alambic Investment Management
California
$29K -$6.38K -540 -20%
Legal & General Group
68
Legal & General Group
United Kingdom
$27K -$3.74K -316 -13%
Royal Bank of Canada
69
Royal Bank of Canada
Ontario, Canada
$21K +$17.8K +1,502 +3,755%
Carson Wealth (CWM LLC)
70
Carson Wealth (CWM LLC)
Nebraska
$17K – – –
AIP
71
Ameritas Investment Partners
Nebraska
$15K – – –
MLICM
72
Metropolitan Life Insurance Company (MetLife)
New York
$14.4K +$12.4K +1,049 New
CG
73
Cutler Group
California
$14K – – –
Simplex Trading
74
Simplex Trading
Illinois
$13K +$11.6K +980 +4,455%
HWM
75
HighMark Wealth Management
Minnesota
$9K – – –
1 2
3
4

KDNY Hedge Fund Activity: Q1 2020 in Review

82 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Chinook Therapeutics, Inc. Common Stock (KDNY) for Q1 2020, worth a combined $110M — up 179% from $39.2M a quarter earlier.

Fund positioning in KDNY was balanced in Q1 2020: 19 funds opened new positions, 19 closed out, 21 added to existing stakes and 29 trimmed.

The largest buyer was Vivo Capital, opening a new position worth an estimated $12.1M. The largest seller was Goldman Sachs, cutting an estimated $1.66M.

  • 82 institutional investors held Chinook Therapeutics, Inc. Common Stock (KDNY) as of Q1 2020, down from 84 in Q4 2019.
  • Funds reported $110M of Chinook Therapeutics, Inc. Common Stock stock for Q1 2020, up 179% quarter-over-quarter.
  • 19 funds opened new Chinook Therapeutics, Inc. Common Stock positions in Q1 2020 and 19 closed out, a net change of 0 holders.
  • The largest Chinook Therapeutics, Inc. Common Stock buyer in Q1 2020 was Vivo Capital, an estimated $12.1M added.
  • The largest Chinook Therapeutics, Inc. Common Stock seller in Q1 2020 was Goldman Sachs, an estimated $1.66M sold.

Based on aggregated 13F filings for Q1 2020.